CARLEY BLEWETT: Open Payments
NPI 1174017883 · NEPTUNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,408 in 142 payments from 19 companies in 2025. Trend: 2023 $1,387 · 2024 $1,467 · 2025 $2,408
Food & beverage: $2,200Education: $208
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $517 |
| Janssen Biotech, Inc. | 11 | $267 |
| Galderma Laboratories, L.P. | 17 | $263 |
| Novartis Pharmaceuticals Corporation | 11 | $243 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $165 |
| Incyte Corporation | 8 | $146 |
| Lilly USA, LLC | 10 | $139 |
| LEO Pharma Inc. | 7 | $131 |
| Regeneron Healthcare Solutions, Inc. | 5 | $89 |
| Arcutis Biotherapeutics, Inc. | 5 | $85 |
Products named: SKYRIZI, TREMFYA, NEMLUVIO, COSENTYX, OPZELURA, TALTZ, RINVOQ, ADBRY.
Industry payments across NJ — which companies pay providers there.
